Introduction
Clarithromycin (6-O-methylerythromycin A), one of the best known macrolide antibiotics, has strong antibacterial activity and good pharmacokinetic properties [1] . Clarithromycin can inhibit H.pylori, which makes it widely used in clinic [2] . Clarithromycin was synthesized after oximation, etherification, silylation, methylation and de-protection with erythromycin A as the starting material in industrial production [3] [4] [5] [6] . There are various relative substances in clarithromycin products [7] , whose type and content can be the direct indicator of the product's quality.
Group protection and region-selective methylation are the most important issues in industrial production of clarithromycin [8] . TMS is used as protecting group of 2'-OH and 4''-OH, derivatives of 6,4''-Di-O-methylerythromycin A will form if 4''-OH isn't protected completely. Furthermore, methylation reaction is accompanied by de-protection reaction. 4''-OTMS is easy to remove under alkaline conditions to form derivatives of 4''-O-methylerythromycin A in methylation procedure [9] . In this article, we synthesized the clarithromycin relative substance 5 and its derivatives 2, 3 and 4 with 1 as the starting material, the reaction pathway can be seen in Fig.1 . Purification of each compound was performed by column chromatography and their structures were determined by C-NMR spectra were recorded in CDCl 3 on ARX500 spectrometer. HPLC was carried out on a 4.6×250mm column of Purospher STAR LP RP-18e (5 um) with 0.067M KH 2 PO 4 (pH4.0) buffer/acetonitrile =55/45.
Synthesis of 2'-O-TMS-6-O-methylerythromycin A 9-[(1-ethoxy-1-methylethyl) oxime](2)
A solution of 1(5.0g, 5.03mmol) in 50ml of THF was treated with 4ml of water and 0.2g 85% KOH powder at 25 . The solution was monitored by TLC (petroleum ether ℃ /ethyl acetate/ diethylamide, 10/1/1). The resultant reaction was added in 20 ml water and then basified (pH=9) using NH 4 Cl solid. The mixture was extracted with petroleum ether and the organic layer was washed successively with saturated brine and water and dried over MgSO 4 . The solvent was 
Synthesis of 2'-O-TMS-6, 4''-Di-O-methylerythromycin A 9-[(1-ethoxy-1-methylethyl)-oxime] (3)
To a solution of 2 (1.0g, 1.08mmol) in 20ml of a mixture of DMSO/THF (1/1) was added CH 3 I (0.5ml, 7.92mmol) and then 85% KOH powder (0.3g, 4.58mmol), and the resulting mixture was stirred at room temperature for 3 hours. The solution was added 20ml of water; stirring was continued for 5 minutes and then extracted with petroleum ether (40ml + 20ml). The organic layer was combined and successively washed with water and saturated brine and then dried over anhydrous MgSO 4 . The solvent was evaporated in vacuo to give 0.7g (69%) of 3 as colorless foam: 
Synthesis of 6,4''-Di-O-methylerythromycin A 9-oxime(4)
To a solution of 3 (0.7g, 0.75mmol) in a mixture of 20ml of ethanol and water (1/1) was added to formic acid (pH4.0) and then stirred under reflux. The reaction was monitored by TLC (petroleum ether/ethyl acetate/diethylamine, 10/4/1). The resulting solution was basified (pH9-10) using 4N NaOH aqueous and the precipitation was washed with water. The crude product was purified by silica gel column chromatography (petroleum ether/ethyl acetate/diethylamine, 10/1/0.5) to afford 0.3g (51.5%) of 4 as a colorless form: 
Synthesis of 6, 4''-Di-O-methylerythromycin A(5)
To a solution of 4 (0.3g, 0.39mmol) in a mixture of 20ml of ethanol and water (1/1) was added to NaHSO 3 and formic acid (pH4.0) and then stirred under reflux. The reaction was monitored by TLC (petroleum ether/ethyl acetate/diethylamine, 10/ 4/1). The resulting solution was basified (pH9-10) using 4N NaOH aqueous and the precipitation was washed with water and afford 0.2g of 5(68.0%) as colorless crystals (the purity was 77.4% determined by HPLC): 28 ( s, 3H, 3''-CH3 ), 1.30 ( d, 3H, 5''-CH3 ), 1.41 ( s, 3H, 6-CH3 
Discussion
In the synthesis of 6, 4''-Di-O-methylerythromycin A and its derivatives, temperature is a crucial issue. The reaction proceeds very slowly and is incomplete when the temperature is too low, while the temperature is too high, much more side effects will occur. For instance, 1 was no longer reduced after one week at 10 , suggesting that the reaction was terminated but the raw material ℃ was not completely reacted. However, it would generate a lot of 6-O-methylerythromycin A 9-[(1-ethoxy-1-methylethyl) oxime] instead of 2 when the temperature was 40℃; 2 generated a variety of byproducts rather than 3 at room temperature in the methylation reaction.
Reaction time is very important on synthesis of 6, 4''-Di-O-methylerythromycin A and its derivatives. 1 generated a large number of 2 and a small amount of 6-O-methylerythromycin A 9-[(1-ethoxy-1-methylethyl)oxime] after 3 days at 25 but a lot of 2 would be converted into ℃ 6-O-methylerythromycin A 9-[(1-ethoxy-1-methylethyl)oxime] after 5 days. It would generate a lot of unknown byproducts when the reaction time was too long in the reaction from 4 to 5, which resulting in the amount of target product reduced. Therefore, it is extremely important to control reaction time. Further studies on optimization of the reaction conditions are needed to obtain a higher yield of 6,4''-Di-O-methylerythromycin A and its derivatives.
